NewsRoom Articles - Page 186 of 591

ThursdayMar 24, 2022 4:20 am

420 with CNW — Canada Introduces Proposal to Increase Marijuana Beverage Purchase Limits

As the cannabis industry matures, the cannabis-infused beverage segment is expected to offer fierce competition to other types of cannabis products. Market experts project that the segment will grow at a compound annual growth rate of 16% to achieve a valuation of $2 billion by 2026. Canada, which first allowed the production and sale of cannabis beverages in late 2019, has proposed a policy change that would allow consumers to purchase more cannabis beverages at one time. The federal government has asked for public comments regarding a proposed change in cannabis regulation that would increase the number of cannabis beverages…

WednesdayMar 23, 2022 4:20 pm

420 with CNW — French Government Announces Decree Allowing Growing of Medical Marijuana

Last month, the French government issued a decree that allowed the growing of medical marijuana and development of the industry. The enactment took effect on March 1, 2022; however, it awaits implementation by regulators. The act features conditions and procedures for the growth and production of medical cannabis. It has also amended some clauses in the Code of Public Health to permit cultivation, production, processing, transport, possession, import and export of cannabis and its components under medical mandate. The development of the medicinal cannabis supply chain will be overseen by the National Agency for the Safety of Medicines and Health…

WednesdayMar 23, 2022 4:20 am

420 with CNW — VA Suicide Prevention Program Will Not Include Cannabis Treatment

Medical cannabis use among veterans has been a hot topic since states first started legalizing marijuana for medical use. While drug-reform proponents believe the plant has the potential to help veterans deal with chronic pain and mood disorders such as anxiety and post-traumatic stress disorder, others say it is federally prohibited for good reasons, with one being that it is a gateway drug with no medical application. This is despite research debunking this reason on numerous occasions. The latter opinion seems to be shared by the U.S. Department of Veteran Affairs (VA), the government body in charge of administrating benefit…

TuesdayMar 22, 2022 4:20 pm

420 with CNW — Federal Report Lists Frequency of Cannabis Drug Tests Across Different Sectors

Last month, the U.S. Bureau of Labor Statistics (BLS) released a labor report that documented drug-testing rates across various industries. Data from the federal report revealed that for the first time in 25 years, workers were asked about the frequency of workplace drug tests. It revealed that drug testing had dropped and some workplaces had either removed or delayed testing their workers for drugs during the COVID-19 pandemic. In the past 25 years, medical marijuana has been legalized in almost three-quarters of all U.S. states while the adult use of marijuana is allowed in one-third of the states. Eighty percent…

TuesdayMar 22, 2022 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces First Phase of Epilepsy Research Using DehydraTECH(TM)-CBD

Lexaria’s patented DehydraTECH(TM) technology provides faster delivery times, increases bioavailability, increases brain absorption, improves drug potency, reduces administration costs, and masks unwanted flavors The epilepsy research will compare the FDA-approved Epidiolex(R) to the company’s proprietary DehydraTECH-CBD formulation The global cannabidiol (“CBD”) market had an estimated value of $2.7 billion in 2021 and is expected to reach $111.8 billion by 2030, driven by an increase in demand for CBD use in health and wellness industries Lexaria Bioscience (NASDAQ: LEXX) (NASDAQ: LEXXW), a global innovator in drug delivery platforms, recently announced that the first phase of its epilepsy research program, EPIL-A21-1, has…

TuesdayMar 22, 2022 4:20 am

420 with CNW — Canada May Soon Change Its Cannabis Beverage Regulations

The “Canada Gazette” recently shared a proposal that may allow more cannabis beverages to be bought in one transaction as well as modify how the marijuana content in drinks was calculated. This is something cannabis retailers, consumers and companies have been championing. The proposal will make a gram of dried marijuana equal to 570 g of a cannabis drink. This is a significant increase from the 70 grams of a cannabis drink authorities currently equate to a gram of dried marijuana. The quantity of marijuana beverages that those of age can possess will also increase to about 17 liters, from…

MondayMar 21, 2022 4:20 pm

420 with CNW — Research Reveals That Marijuana Can Lower BMI, Reduce Inflammation

According to a new study, including cannabis in your diet and lifestyle can go a long way in reducing weight and fighting inflammation. Doctors recommend maintaining a healthy weight in order to prevent the disorders associated with obesity. This includes diabetes, cancer, stroke and heart diseases. Systemic inflammation, on the other hand, can lead to fatal ailments including autoimmune conditions, cardiovascular diseases and neurodegenerative disorders. It is relatively unclear how obesity triggers body inflammations. Scientists have said, however, that more weight means that the body has more inflammation while weight reduction leads to less inflammation. The new study revealed the…

MondayMar 21, 2022 9:15 am

Lexaria Bioscience Corp.’s (NASDAQ: LEXX) Intellectual Property Portfolio Grows Following Receipt of 24th Granted Patent

Lexaria has received a new patent entitled “Compositions Infused with Nicotine Compounds and Methods of Use Thereof” The new patent, granted in Australia, is the first awarded from Lexaria’s 8th patent family and offers IP protection across a total of 9 claims Lexaria believes the patent could be meaningful as it seeks to build value With the new patent, Lexaria’s IP portfolio has now grown to 24 granted patents worldwide In his letter to shareholders dated January 27, 2022, Lexaria Bioscience (NASDAQ: LEXX) CEO Chris Bunka documented the company’s expectation that it would receive additional patents in 2022. The expected…

MondayMar 21, 2022 9:00 am

Flora Growth Corp. (NASDAQ: FLGC) Writing the Playbook on M&A

Flora Growth’s two late 2021 acquisitions added an estimated $35 million in revenue and $7 million in EBITDA Its acquisition of Vessel Brand Inc. is projected to bring $35-$45 million in revenue for the 2022 calendar year With these acquisitions, the company, an internationally focused cannabis brand builder with a global distribution platform, stamps its position as an undisputed market and M&A leader In 2021, Flora Growth (NASDAQ: FLGC) completed its Initial Public Offering (“IPO”) and closed the acquisition of Vessel Brand Inc., a direct-to-consumer (“DTC”) business. The company also formed a joint venture to see the KaLaya brand's distribution…

MondayMar 21, 2022 4:20 am

420 with CNW — Factors Cannabis Retailers Should Consider When Choosing a Point-of-Sale System

A point-of-sale system enables business owners to keep track of their sales while also accepting payments from their consumers. Buying a system for a cannabis store seems like an easy feat, but it is not. There are a number of factors that cannabis retailers need to take into account when choosing a point-of-sale (POS) system for their store. POS experts, consultants and marijuana retail designers all recommend that cannabis retailers choose systems with features that support their brand and operations, as well as their business model. Given that a POS system helps retailers run their businesses, it is important that…

News and publishing service for cannabis related companies

Contact us: 512.354.7000